Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | DF6215 |
Trade Name | |
Synonyms | DF-6215|DF 6215 |
Drug Descriptions |
DF6215 is a modified version of IL-2 that acts as an agonist for IL2R, which potentially activates cytotoxic CD8-positive T-lymphocytes and NK cells, resulting in antitumor activity (Journal for ImmunoTherapy of Cancer 2024;12). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C203655 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
DF6215 | DF6215 | 0 | 1 |